Cargando…

Medication use in populations exposed to the 2010 Eyjafjallajökull eruption: an interrupted time series analysis

OBJECTIVES: To assess the trends in medication use indicative of physical and psychological morbidity following the 2010 volcanic eruption in Eyjafjallajökull immediately after and during a 3-year period following the eruption. DESIGN: Population-based register study. SETTING: Eyjafjallajökull erupt...

Descripción completa

Detalles Bibliográficos
Autores principales: Guðmundsdóttir, Rebekka Björg, Jónsson, Brynjólfur Gauti Guðrúnar, Valdimarsdottir, Unnur, Carlsen, Hanne Krage, Hlodversdottir, Heidrun, Song, Huan, Thordardottir, Edda Bjork, Pétursdóttir, Guðrún, Briem, Haraldur, Gislason, Thorarinn, Gudnason, Thorolfur, Thorsteinsson, Thröstur, Zoega, Helga, Hauksdóttir, Arna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9086619/
https://www.ncbi.nlm.nih.gov/pubmed/35534080
http://dx.doi.org/10.1136/bmjopen-2021-059375
_version_ 1784704044979191808
author Guðmundsdóttir, Rebekka Björg
Jónsson, Brynjólfur Gauti Guðrúnar
Valdimarsdottir, Unnur
Carlsen, Hanne Krage
Hlodversdottir, Heidrun
Song, Huan
Thordardottir, Edda Bjork
Pétursdóttir, Guðrún
Briem, Haraldur
Gislason, Thorarinn
Gudnason, Thorolfur
Thorsteinsson, Thröstur
Zoega, Helga
Hauksdóttir, Arna
author_facet Guðmundsdóttir, Rebekka Björg
Jónsson, Brynjólfur Gauti Guðrúnar
Valdimarsdottir, Unnur
Carlsen, Hanne Krage
Hlodversdottir, Heidrun
Song, Huan
Thordardottir, Edda Bjork
Pétursdóttir, Guðrún
Briem, Haraldur
Gislason, Thorarinn
Gudnason, Thorolfur
Thorsteinsson, Thröstur
Zoega, Helga
Hauksdóttir, Arna
author_sort Guðmundsdóttir, Rebekka Björg
collection PubMed
description OBJECTIVES: To assess the trends in medication use indicative of physical and psychological morbidity following the 2010 volcanic eruption in Eyjafjallajökull immediately after and during a 3-year period following the eruption. DESIGN: Population-based register study. SETTING: Eyjafjallajökull eruption in Iceland, 2007–2013. PARTICIPANTS: All residents in Iceland who received at least one medication dispensing were identified. Residents of exposed areas were classified into exposure groups (individual-level data) and residents in other parts of Iceland were included as a non-exposed group (aggregated data). INTERVENTION/EXPOSURE: Eyjafjallajökull erupted on 14 April 2010 and continued for 39 days, producing heavy ash fall in South Iceland. MAIN OUTCOME MEASURES: Using interrupted time series analysis, we examined annual and quarterly changes in medicine use, measured as number of dispensed defined daily dose (DDD) per 1000 individuals. We calculated the level shift (immediate change) and change in slope from pre-eruption to post-eruption (long-term change) in medication dispensing. RESULTS: Among exposed residents, there was a 6% decrease (95% CI -7% to -4%) in the annual number of dispensed DDDs 1-year post-eruption in the overall medication class, including analgesics (−5%, 95% CI -6% to -3%), hypnotics and sedatives (−9%, 95% CI -11% to -7%) and respiratory medications (−7%, 95% CI -9% to -5%; −8%, 95% CI -11% to -4%). Simultaneously, there was a 9% decrease (95% CI -14% to -4%) in the overall medication class among non-exposed residents. Moreover, among exposed residents, we observed change in slope of −4% (95% CI -7% to -1%) in the overall medication class, including for analgesics (−6%, 95% CI -8% to -3%) and other respiratory drugs (−10%, 95% CI -16% to -4%). CONCLUSION: Our findings indicate that the eruption did not lead to increases in medication dispensing among residents of exposed areas, rather decreases for some medicine classes. The results should be interpreted with caution since the content of each eruption differs.
format Online
Article
Text
id pubmed-9086619
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-90866192022-05-20 Medication use in populations exposed to the 2010 Eyjafjallajökull eruption: an interrupted time series analysis Guðmundsdóttir, Rebekka Björg Jónsson, Brynjólfur Gauti Guðrúnar Valdimarsdottir, Unnur Carlsen, Hanne Krage Hlodversdottir, Heidrun Song, Huan Thordardottir, Edda Bjork Pétursdóttir, Guðrún Briem, Haraldur Gislason, Thorarinn Gudnason, Thorolfur Thorsteinsson, Thröstur Zoega, Helga Hauksdóttir, Arna BMJ Open Public Health OBJECTIVES: To assess the trends in medication use indicative of physical and psychological morbidity following the 2010 volcanic eruption in Eyjafjallajökull immediately after and during a 3-year period following the eruption. DESIGN: Population-based register study. SETTING: Eyjafjallajökull eruption in Iceland, 2007–2013. PARTICIPANTS: All residents in Iceland who received at least one medication dispensing were identified. Residents of exposed areas were classified into exposure groups (individual-level data) and residents in other parts of Iceland were included as a non-exposed group (aggregated data). INTERVENTION/EXPOSURE: Eyjafjallajökull erupted on 14 April 2010 and continued for 39 days, producing heavy ash fall in South Iceland. MAIN OUTCOME MEASURES: Using interrupted time series analysis, we examined annual and quarterly changes in medicine use, measured as number of dispensed defined daily dose (DDD) per 1000 individuals. We calculated the level shift (immediate change) and change in slope from pre-eruption to post-eruption (long-term change) in medication dispensing. RESULTS: Among exposed residents, there was a 6% decrease (95% CI -7% to -4%) in the annual number of dispensed DDDs 1-year post-eruption in the overall medication class, including analgesics (−5%, 95% CI -6% to -3%), hypnotics and sedatives (−9%, 95% CI -11% to -7%) and respiratory medications (−7%, 95% CI -9% to -5%; −8%, 95% CI -11% to -4%). Simultaneously, there was a 9% decrease (95% CI -14% to -4%) in the overall medication class among non-exposed residents. Moreover, among exposed residents, we observed change in slope of −4% (95% CI -7% to -1%) in the overall medication class, including for analgesics (−6%, 95% CI -8% to -3%) and other respiratory drugs (−10%, 95% CI -16% to -4%). CONCLUSION: Our findings indicate that the eruption did not lead to increases in medication dispensing among residents of exposed areas, rather decreases for some medicine classes. The results should be interpreted with caution since the content of each eruption differs. BMJ Publishing Group 2022-05-09 /pmc/articles/PMC9086619/ /pubmed/35534080 http://dx.doi.org/10.1136/bmjopen-2021-059375 Text en © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Public Health
Guðmundsdóttir, Rebekka Björg
Jónsson, Brynjólfur Gauti Guðrúnar
Valdimarsdottir, Unnur
Carlsen, Hanne Krage
Hlodversdottir, Heidrun
Song, Huan
Thordardottir, Edda Bjork
Pétursdóttir, Guðrún
Briem, Haraldur
Gislason, Thorarinn
Gudnason, Thorolfur
Thorsteinsson, Thröstur
Zoega, Helga
Hauksdóttir, Arna
Medication use in populations exposed to the 2010 Eyjafjallajökull eruption: an interrupted time series analysis
title Medication use in populations exposed to the 2010 Eyjafjallajökull eruption: an interrupted time series analysis
title_full Medication use in populations exposed to the 2010 Eyjafjallajökull eruption: an interrupted time series analysis
title_fullStr Medication use in populations exposed to the 2010 Eyjafjallajökull eruption: an interrupted time series analysis
title_full_unstemmed Medication use in populations exposed to the 2010 Eyjafjallajökull eruption: an interrupted time series analysis
title_short Medication use in populations exposed to the 2010 Eyjafjallajökull eruption: an interrupted time series analysis
title_sort medication use in populations exposed to the 2010 eyjafjallajökull eruption: an interrupted time series analysis
topic Public Health
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9086619/
https://www.ncbi.nlm.nih.gov/pubmed/35534080
http://dx.doi.org/10.1136/bmjopen-2021-059375
work_keys_str_mv AT guðmundsdottirrebekkabjorg medicationuseinpopulationsexposedtothe2010eyjafjallajokulleruptionaninterruptedtimeseriesanalysis
AT jonssonbrynjolfurgautiguðrunar medicationuseinpopulationsexposedtothe2010eyjafjallajokulleruptionaninterruptedtimeseriesanalysis
AT valdimarsdottirunnur medicationuseinpopulationsexposedtothe2010eyjafjallajokulleruptionaninterruptedtimeseriesanalysis
AT carlsenhannekrage medicationuseinpopulationsexposedtothe2010eyjafjallajokulleruptionaninterruptedtimeseriesanalysis
AT hlodversdottirheidrun medicationuseinpopulationsexposedtothe2010eyjafjallajokulleruptionaninterruptedtimeseriesanalysis
AT songhuan medicationuseinpopulationsexposedtothe2010eyjafjallajokulleruptionaninterruptedtimeseriesanalysis
AT thordardottireddabjork medicationuseinpopulationsexposedtothe2010eyjafjallajokulleruptionaninterruptedtimeseriesanalysis
AT petursdottirguðrun medicationuseinpopulationsexposedtothe2010eyjafjallajokulleruptionaninterruptedtimeseriesanalysis
AT briemharaldur medicationuseinpopulationsexposedtothe2010eyjafjallajokulleruptionaninterruptedtimeseriesanalysis
AT gislasonthorarinn medicationuseinpopulationsexposedtothe2010eyjafjallajokulleruptionaninterruptedtimeseriesanalysis
AT gudnasonthorolfur medicationuseinpopulationsexposedtothe2010eyjafjallajokulleruptionaninterruptedtimeseriesanalysis
AT thorsteinssonthrostur medicationuseinpopulationsexposedtothe2010eyjafjallajokulleruptionaninterruptedtimeseriesanalysis
AT zoegahelga medicationuseinpopulationsexposedtothe2010eyjafjallajokulleruptionaninterruptedtimeseriesanalysis
AT hauksdottirarna medicationuseinpopulationsexposedtothe2010eyjafjallajokulleruptionaninterruptedtimeseriesanalysis